Related Experiment Video
Updated: Aug 21, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Long COVID: Rapid Evidence Review
Eric Herman1, Elizabeth Shih1, Anthony Cheng1
1Oregon Health and Science University, Portland, Oregon.
Postacute sequelae of COVID-19 (long COVID) affects millions, presenting diverse symptoms beyond 28 days. Management focuses on holistic strategies and supportive care, as medication evidence is lacking.
Area of Science:
- Infectious Diseases
- Public Health
- Internal Medicine
Background:
- Postacute sequelae of COVID-19, or long COVID, impacts 10-30% of COVID-19 survivors.
- Symptoms persist beyond 28 days, with diagnosis not requiring a positive test.
- Long COVID presents with diverse symptoms like fatigue, cognitive impairment, and dyspnea.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Myocarditis II: Clinical Features and Diagnostic Tests

